C-(1-Methyl-1H-pyrazol-4-yl)-methylamine, 95.0%, 250mg

Matraces aforados con tapón de vidrio, clase A Vidrio transparente, 10 ml, 10/19, 2 Pieza(s)

N2-(1H-1,3-benzodiazol-6-yl)-N4-(3-cyclopropyl-1H-pyrazol-5-yl)pyrimidine-2,4-diamine, 98%, 25mg

4-Bromo-1-chloroisoquinoline, 97.0%, 1g

(R)-4-Phenyl-3-propionyloxazolidin-2-one, 95.0%, 25g

2-Fluoro-4-methylbenzenesulfonamide, 97.0%, 1g

2',3'-dichloro-3-(4-methoxyphenyl)propiophenone, 97.0%, 1g

4-Bromo-1-fluoro-2-(2,2,2-trifluoroethyl)benzene, 95.0%, 250mg

5-Bromo-2-(trifluoromethyl)benzene-1-sulfonyl chloride, 97.0%, 5g

2-Allyl-5,5-dimethyl-1,3,2-dioxaborinane, 98% (stabilized with Phenothiazine), 1g

2,5-Dichlorobenzothiazole, 95.0%, 10g

6-chloro-2-(methylsulfanyl)-3,4-dihydropyrimidin-4-one, 95%, 250mg

1-((tert-Butoxycarbonyl)(methyl)amino)cyclobutanecarboxylic acid, 95%, 1g